Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

NCT04868045 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Thyroid Cancer

Interventions

DRUG: Thyrotropin Releasing Hormone (TRH)
DRUG: levothyroxine
OTHER: Hypothyroidism QOL questionnaire

Sponsor

Memorial Sloan Kettering Cancer Center